WHC is still in active development. Read this to understand our approach.
depiction of LNNWVNGFPYWNQE-UHFFFAOYSA-N.svg
psychonaut

Desomorphine

Verificar en psychonaut

isomerdesign

Desomorphine

Verificar en isomerdesign

pubchem

Desomorphine

Verificar en pubchem

wiki

Desomorphine

Verificar en wiki

Data

InChI: InChI=1S/C17H21NO2/c1-18-8-7-17-11-3-2-4-14(17)20-16-13(19)6-5-10(15(16)17)9-12(11)18/h5-6,11-12,14,19H,2-4,7-9H2,1H3

Sinónimos: Permonid,DEA No. 9055,Deoxydihydromorphine D,(4R,4aR,7aS,12bS)-3-methyl-2,4,4a,5,6,7,7a,13-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-9-ol,6-Deoxy-7,8-dihydromorphine,(4R,4aR,7aS,12bS)-3-methyl-2,4,4a,5,6,7,7a,13-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-9-ol,Dihydrodesoxymorphine D,Desomorphine solution, 1 mg/mL in acetonitrile, ampule of 1 mL, certified reference material,Desomorphinum [INN-Latin],Dihydrodeoxymorphine or 4,5-Epoxy-3-hydroxy-N-methylmorphinan,Desomorphine [INN:BAN:DCF],Desomorfina [INN-Spanish],Dihydrodesoxymorphine-D,EINECS 207-045-7,DESOMORPHINE [MI],SCHEMBL24969,Desomorfina,4,5-Epoxy-3-hydroxy-N-methylmorphinan,DB01531,Desomorfin,427-00-9,Desomorphinum,Desomorfin [Czech],Desomorphine,Dihydrodeoxymorphine,Krokodil,IDS-ND-002(SECT.3),Krokodil [Street Name],DESOMORPHINE [INN],Crocodile [Street Name],UNII-7OP86J5E33,IDS-ND-002,Permoid,ZINC4215567,Q422163,7OP86J5E33,CHEMBL2106274,Morphinan-3-ol, 4,5-alpha-epoxy-17-methyl-,HSDB 8070,DTXSID10195390,CHEBI:135119,Desomorphine (Dihydrodesoxymorphine; Krokodil) 1.0 mg/ml in Acetonitrile,Morphine, 6-deoxy-7,8-dihydro-,Dihydrodesoxymorphine,(1S,5R,13S,17R)-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0?,??.0?,??.0?,??]octadeca-7,9,11(18)-trien-10-ol


Estimated data

Solubilidad: -3.033 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 99.4% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.